Anthrax

Definition & Overview

Anthrax is a peracute, highly fatal, zoonotic infectious disease of cattle and other herbivores caused by the spore-forming bacterium Bacillus anthracis. It is characterized by sudden death, severe systemic toxemia, hemorrhagic septicemia, and the rapid decomposition of carcasses with unclotted blood exuding from natural orifices. The disease is of major economic and public health importance due to its high mortality, potential for large outbreaks, and the risk of human infection. In cattle, anthrax typically manifests as peracute or acute septicemia, with death occurring within 24 to 48 hours of exposure. The disease is notifiable to veterinary authorities in most countries, and strict biosecurity measures are essential to prevent its spread. Anthrax is a classic example of a soil-borne disease, with spores persisting in the environment for decades, making eradication difficult. The economic impact includes direct losses from mortality, costs of quarantine, carcass disposal, decontamination, and trade restrictions. In endemic regions, annual vaccination is the cornerstone of prevention.

Etiology & Causes

The causative agent is Bacillus anthracis, a Gram-positive, aerobic, spore-forming, rod-shaped bacterium. The vegetative form is non-motile, capsulated, and produces two major virulence factors: a polypeptide capsule (poly-D-glutamic acid) that is antiphagocytic, and a tripartite toxin composed of protective antigen (PA), lethal factor (LF), and edema factor (EF). The toxin components act synergistically: PA binds to host cell receptors and mediates the entry of LF and EF into the cytosol. LF is a zinc-dependent metalloprotease that cleaves mitogen-activated protein kinase kinases (MAPKKs), leading to macrophage apoptosis and disruption of cell signaling. EF is a calmodulin-dependent adenylate cyclase that increases intracellular cyclic AMP, causing edema and impaired host immune function. The capsule prevents phagocytosis and allows the bacteria to multiply unchecked in the bloodstream. Spores are highly resistant to environmental extremes, including heat, desiccation, and disinfectants, and can remain viable in soil for decades. The vegetative form is fragile and does not survive outside the host. The bacterium is classified under the Bacillus cereus group, and its pathogenicity is largely determined by the presence of the pXO1 and pXO2 plasmids, which encode the toxin and capsule, respectively.

Epidemiology

Anthrax occurs worldwide, with endemic foci in regions with alkaline, calcareous, or nitrogen-rich soils, such as parts of Africa, Asia, Australia, and the Americas. In cattle, the disease is most common in grazing animals, particularly in areas where soil contamination is high. Outbreaks are often associated with environmental disturbances such as flooding, drought, or excavation that bring spores to the surface. The incidence is typically sporadic, but epizootics can occur under favorable conditions. Age and breed susceptibility vary; young cattle are more susceptible than older animals, and certain breeds may have higher resistance. The disease is more prevalent in the summer and autumn months, possibly due to increased spore survival and vector activity. Morbidity in an affected herd can range from 1% to 20%, but mortality is nearly 100% in untreated cases. The economic impact is significant, including direct losses from death, costs of vaccination, carcass disposal, and trade restrictions. The zoonotic risk is high, especially for veterinarians, farmers, and slaughterhouse workers who handle infected carcasses or contaminated products.

Pathophysiology

The pathogenesis of anthrax begins with the ingestion or inhalation of spores. In cattle, the most common route is ingestion of contaminated soil or feed. Spores are taken up by macrophages in the gastrointestinal tract and transported to regional lymph nodes, where they germinate into vegetative forms. The vegetative bacteria multiply locally, producing the capsule and toxins, which cause edema and necrosis. The bacteria then enter the bloodstream, leading to massive septicemia and toxemia. The lethal toxin (LT) and edema toxin (ET) act systemically: LT induces macrophage apoptosis and release of pro-inflammatory cytokines (TNF-alpha, IL-1beta), leading to systemic inflammatory response syndrome (SIRS), vascular leakage, and shock. ET increases cAMP levels, causing edema and impaired neutrophil function. The capsule prevents phagocytosis, allowing bacterial numbers to reach 10^8 to 10^9 organisms per milliliter of blood. The terminal event is often acute respiratory distress and cardiovascular collapse. In peracute cases, death occurs before clinical signs are observed. In acute cases, clinical signs include fever, depression, dyspnea, and bloody discharges. The disease is characterized by hemorrhagic lymphadenitis, splenomegaly, and widespread petechial hemorrhages on serosal surfaces.

Predisposing Risk Factors

Intrinsic factors include age (young cattle are more susceptible), breed (some breeds may have genetic resistance), and immune status (immunosuppression due to stress or concurrent disease increases susceptibility). Extrinsic factors include environmental conditions that favor spore survival and transmission, such as alkaline soils, high organic matter, and warm temperatures. Management practices that disturb soil, such as plowing, drainage, or construction, can bring spores to the surface. Flooding can spread spores over large areas. Poor biosecurity, such as inadequate carcass disposal, can contaminate the environment. In endemic areas, lack of vaccination is a major risk factor. Additionally, feeding contaminated bone meal or other animal by-products can introduce the disease into a herd.

Clinical Signs & Symptoms

In cattle, anthrax can present in peracute, acute, or subacute forms. The peracute form is most common and is characterized by sudden death, often without premonitory signs. Animals may be found dead with blood-stained discharges from the nose, mouth, and anus. The acute form presents with fever (up to 41.5Β°C), depression, anorexia, tachycardia, tachypnea, and dyspnea. There may be swelling of the throat, neck, and brisket due to edema. Mucous membranes are congested and petechiated. Bloody diarrhea and hematuria may occur. Pregnant cows may abort. The subacute form is less common and may show localized edema and mild systemic signs. In all cases, the carcass undergoes rapid decomposition, and unclotted blood exudes from natural orifices. The spleen is typically enlarged and dark, and the blood is tarry and fails to clot. Diagnosis is often based on the characteristic postmortem findings and confirmed by laboratory testing.

Differential Diagnoses

Differential diagnoses include other causes of sudden death in cattle, such as blackleg (Clostridium chauvoei), malignant edema (Clostridium septicum), lightning strike, acute lead poisoning, and severe parasitism. Blackleg typically affects young cattle and presents with crepitant swelling of large muscles. Malignant edema is associated with wound contamination and presents with subcutaneous edema and gas. Lightning strike is often associated with a history of storms and may affect multiple animals. Lead poisoning can cause neurological signs and gastrointestinal stasis. Other septicemic diseases, such as salmonellosis and pasteurellosis, may also cause sudden death but are less acute. Rabies should be considered if neurological signs are present. The presence of unclotted blood from orifices and the rapid decomposition of the carcass are highly suggestive of anthrax. Laboratory confirmation is essential, as anthrax is a notifiable disease.

Diagnostic Algorithm & Approach

The diagnostic approach begins with a thorough history and clinical examination. If anthrax is suspected, the carcass should not be opened, as this can release spores. A blood sample should be taken from a peripheral vein (e.g., jugular) using a sterile syringe and needle, and smears should be made for microscopic examination. The blood should be cultured on blood agar. Alternatively, a thin blood smear can be stained with polychrome methylene blue (M'Fadyean reaction) to demonstrate the characteristic encapsulated bacilli. Rapid diagnostic tests, such as polymerase chain reaction (PCR) and enzyme-linked immunosorbent assay (ELISA), are available for confirmation. If the carcass has been opened, tissue samples (spleen, lymph nodes, and blood) should be collected and submitted to a diagnostic laboratory. In the field, the presence of anthrax should be suspected based on sudden death, blood-stained discharges, and the absence of rigor mortis. Definitive diagnosis requires laboratory confirmation, and the disease must be reported to the relevant veterinary authorities.

Laboratory Findings (CBC & Biochemistry)

Laboratory findings in anthrax include the presence of Bacillus anthracis in blood smears, which appear as large, Gram-positive, encapsulated rods. The M'Fadyean reaction, using polychrome methylene blue, shows blue-black bacilli with pink capsules. Blood cultures yield characteristic colonies that are non-hemolytic, gray-white, and have a 'curled hair' appearance. PCR assays detect the pXO1 and pXO2 plasmid genes. Serological tests, such as ELISA, can detect antibodies in surviving animals. Hematological findings may include leukopenia or leukocytosis, but these are not specific. In peracute cases, blood may be dark and tarry, and clotting is impaired. Postmortem findings include splenomegaly, hemorrhagic lymphadenitis, and widespread petechial hemorrhages. The spleen is typically dark, soft, and enlarged. The blood is unclotted and may be positive for the organism.

Diagnostic Imaging (Radiography / Ultrasound)

Imaging is not typically used in the diagnosis of anthrax, as the disease is usually diagnosed based on clinical signs and laboratory tests. However, if imaging is performed, radiography may show no specific changes. Ultrasonography may reveal edema and fluid accumulation in the thorax and abdomen, but these findings are non-specific. In a research setting, advanced imaging techniques such as computed tomography (CT) or magnetic resonance imaging (MRI) may be used to study the pathogenesis, but they are not practical in the field. The primary diagnostic tools are microbiological and molecular.

Cytology & Histopathology

Cytological examination of blood smears stained with polychrome methylene blue reveals the characteristic encapsulated bacilli. Histopathological examination of tissues from necropsy shows extensive hemorrhage, edema, and necrosis. The spleen is markedly enlarged with depletion of lymphoid follicles and massive numbers of bacilli. Lymph nodes show hemorrhagic necrosis. The lungs may show congestion and edema. The liver and kidneys may have degenerative changes. The meninges may be congested. The presence of bacilli in the blood and tissues is pathognomonic.

Treatment & Management Protocols

Treatment of anthrax in cattle is often ineffective in peracute cases, as death occurs rapidly. However, in acute cases, early treatment with high doses of antibiotics may be successful. Penicillin is the drug of choice, administered at 20,000 to 40,000 IU/kg IV or IM, every 12 hours. Oxytetracycline (10 mg/kg IV or IM) is an alternative. Supportive therapy includes intravenous fluids and anti-inflammatory drugs. In an outbreak, all exposed animals should be treated with antibiotics and vaccinated. However, vaccination should not be used in animals that are already incubating the disease, as it may precipitate clinical signs. The carcass must be disposed of properly, either by incineration or deep burial with quicklime, to prevent environmental contamination. Quarantine and movement restrictions should be implemented. In endemic areas, annual vaccination with a live attenuated spore vaccine is recommended.

Prognosis

The prognosis for cattle with clinical anthrax is extremely poor, with mortality approaching 100% if untreated. Even with treatment, the survival rate is low, especially in peracute cases. In acute cases, early treatment may result in recovery, but the animal may have long-term sequelae. The prognosis for the herd is guarded, as the disease can spread rapidly. The economic impact is severe, and the herd may be quarantined for an extended period. The risk of recurrence is high if spores persist in the environment. Therefore, vaccination and strict biosecurity are essential for long-term control.

Follow-up & Monitoring

After an outbreak, the herd should be monitored closely for any new cases. Vaccination should be administered to all susceptible animals, and a booster should be given annually. The environment should be decontaminated, and carcasses should be disposed of properly. Soil testing may be recommended to assess spore contamination. Movement restrictions should be lifted only after a period of no new cases. The herd should be observed for at least 30 days after the last case. In endemic areas, a vaccination program should be implemented. The public health authorities should be notified, and farm workers should be educated about the risks and preventive measures.

Clinical Pearls & Pitfalls

Key pearls: Always suspect anthrax in cases of sudden death in grazing cattle, especially in endemic areas. Do not open the carcass if anthrax is suspected; instead, take a blood sample from a peripheral vein. Use the M'Fadyean reaction for rapid field diagnosis. Administer antibiotics early in acute cases. Vaccinate all exposed animals, but avoid vaccinating animals that are already incubating the disease. Pitfalls: Opening the carcass can release spores and contaminate the environment. Delaying treatment can result in death. Using antibiotics without vaccination may not prevent outbreaks. Improper carcass disposal can lead to long-term contamination. Failure to report the disease can result in legal consequences.

Current Drug Dosage Protocols

For treatment of acute anthrax in cattle: Procaine penicillin G at 20,000 IU/kg IM every 12 hours for 5-7 days, or oxytetracycline at 10 mg/kg IV or IM every 24 hours for 3-5 days. Supportive therapy: intravenous fluids (e.g., isotonic saline or lactated Ringer's solution) at 20-40 mL/kg/day, and flunixin meglumine at 1.1-2.2 mg/kg IV for anti-inflammatory effects. For prophylaxis in exposed animals: long-acting oxytetracycline at 20 mg/kg IM once. Vaccination: live attenuated spore vaccine (e.g., Sterne strain) administered subcutaneously at 1 mL per animal, with annual boosters. Withdrawal times: Penicillin has a meat withdrawal of 5 days and milk withdrawal of 3 days; oxytetracycline has a meat withdrawal of 28 days and milk withdrawal of 96 hours. Always consult the label and local regulations.

Evidence-Based Literature Summary

Anthrax is a well-studied disease, with extensive literature on its epidemiology, pathogenesis, and control. Key references include the World Organisation for Animal Health (OIE) Terrestrial Manual, which provides guidelines for diagnosis and vaccination. Studies have demonstrated the efficacy of annual vaccination in reducing outbreaks. Research on the molecular pathogenesis has identified the roles of the toxin components and capsule. Field trials have shown that early treatment with penicillin can reduce mortality. The use of PCR has improved diagnostic accuracy. The importance of biosecurity and proper carcass disposal is emphasized in many reports. The disease remains a significant threat in endemic regions, and ongoing research focuses on improving vaccines and diagnostic tools.

References & Bibliography

  • πŸ“š Rebhun's Diseases of Dairy Cattle (Divers & Peek)
  • πŸ“š Veterinary Medicine: Diseases of Cattle, Horses, Sheep, Pigs and Goats (Constable et al.)
  • πŸ“š Bovine Medicine: Diseases and Husbandry of Cattle (Cockcroft)
  • πŸ“š Plumb's Veterinary Drug Handbook
  • πŸ“š Journal of Dairy Science & AABP / ECBHM Consensus Guidelines